Alcidon enters resellers agreement with Better by Marand
- 13 May 2019
A provider which alerts hospital staff when patients are at risk of harm as made an agreement with healthcare software provider Better by Marand to help tackle medication errors.
Alcidon, which is the parent company of Patientrack, will resell Better By Marand’s OPENeP electronic prescribing and medicines administration system, alongside its next generation patient safety platform, to hospitals in the UK, Australia and New Zealand.
OPENeP, which has been chosen by the likes of Taunton and Somerset NHS Foundation Trust and University Hospitals Plymouth NHS Trust, will now be made available to Alcidion customers.
Donald Kennedy, general manager for Alcidion in the UK, said: “This partnership will undoubtedly interest many of the NHS hospitals we work with to enhance patient safety and the working lives of healthcare professionals.
“This is an important step in our expanding offering to hospitals that are determined to use digital technology to make it easier for staff to deliver safer and better care for patients. We continue to listen to and respond quickly to the needs of the NHS.”
OPENeP is a closed loop electronic medication management system that enables proper adherence to medication administration, such as delivering the right dosage to the right patient at the right time, and provides clinical decision support for complex prescribing scenarios including order sets, IVs, titration and anti-microbial stewardship.
Roko Malkoč, OPENeP product manager, adds: “Patients should be the focus, and it is in their interest to always get accurate treatment of the highest quality.
“By collaborating with Alcidion, we aim to create an environment that maximises patient safety, improves collaboration among staff, and prevents unnecessary errors. All this will lead to better patient outcomes.”
1 Comments
What happened to Marand/Better open sourcing OpenEP? There was lots of press about this from NHS Digital and Plymouth – but we’ve yet to see the code? Is it no longer an open source product?
Comments are closed.